Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
Year: 2012
Type: article
Study design: Clinical Trial
Source: Cancer Immunology Immunotherapy
Institutions: KU Leuven, Universitair Ziekenhuis Leuven
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2072838309
